Solid Tumor, Adult Clinical Trials

294 clinical trials for Solid Tumor, Adult across international registries, including 84 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer — RECRUITING · NA
• Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms — RECRUITING · PHASE1
• A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring — RECRUITING · PHASE1
• Advanced or Recurrent Solid Tumors Treated With SHetA2 — RECRUITING · PHASE1
• Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations — RECRUITING · PHASE1
• Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors — RECRUITING · PHASE1
• First In Human Study of CX-2051 in Advanced Solid Tumors — RECRUITING · PHASE1
• ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu — RECRUITING · PHASE1
• Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values — RECRUITING · NA
• IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors — RECRUITING · PHASE1
• First In Human Study of CX-801 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• BBO-11818 in Adult Subjects With KRAS Mutant Cancer — RECRUITING · PHASE1
• Intravital Microscopy in Human Solid Tumors — RECRUITING · NA
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing — RECRUITING
• A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours — RECRUITING · PHASE1
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors — RECRUITING · PHASE2
• COAST Therapy in Advanced Solid Tumors and Prostate Cancer — RECRUITING · PHASE1
• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors — RECRUITING · PHASE1
• GT201 Injection For The Treatment Of Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors — RECRUITING · PHASE1
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — RECRUITING · PHASE1
• A Study of HQP1351 in Patients With GIST or Other Solid Tumors — RECRUITING · PHASE1
• A Study of VET3-TGI in Patients With Solid Tumors — RECRUITING · PHASE1
• Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors — RECRUITING · PHASE1
• Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy — RECRUITING · NA
• A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors — RECRUITING · PHASE1
• A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. — RECRUITING
• Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• 64Cu-GRIP B in Patients With Advanced Malignancies — RECRUITING · PHASE1
• Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma — RECRUITING · PHASE1
• Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours — RECRUITING · NA
• A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors — RECRUITING · PHASE1
• HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors — RECRUITING · PHASE1
• Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion — RECRUITING · PHASE2
• Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer — RECRUITING · PHASE1
• Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) — RECRUITING · PHASE1
• A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs — RECRUITING · PHASE1
• Psychotherapy Intervention for Latinos With Adv Cancer — RECRUITING · NA
• Psychotherapy Intervention for Latinos With Advanced Cancer — RECRUITING · NA
• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — RECRUITING · PHASE1
• Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1

Refine this search